[HTML][HTML] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane… - The Lancet …, 2018 - thelancet.com
Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

[HTML][HTML] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane… - The Lancet …, 2018 - portal.findresearcher.sdu.dk
BACKGROUND: The benefits and safety of medications for attention-deficit hyperactivity
disorder (ADHD) remain controversial, and guidelines are inconsistent on which …

[HTML][HTML] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane… - The Lancet …, 2018 - ncbi.nlm.nih.gov
Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

[HTML][HTML] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane… - Lancet …, 2018 - discovery.dundee.ac.uk
Background: The benefits and safety of medications for attention-deficit hyperactivity
disorder (ADHD) remain controversial, and guidelines are inconsistent on which …

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network …

S Cortese, N Adamo, C Del Giovane… - The lancet …, 2018 - folia.unifr.ch
METHODS We did a literature search for published and unpublished double-blind
randomised controlled trials comparing amphetamines (including lisdexamfetamine) …

[PDF][PDF] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen… - Lancet, 2018 - kclpure.kcl.ac.uk
Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network …

S Cortese, N Adamo, C Del Giovane… - The Lancet …, 2018 - boris.unibe.ch
BACKGROUND The benefits and safety of medications for attention-deficit hyperactivity
disorder (ADHD) remain controversial, and guidelines are inconsistent on which …

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network …

S Cortese, N Adamo, C Del Giovane… - The Lancet …, 2018 - infona.pl
The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD)
remain controversial, and guidelines are inconsistent on which medications are preferred …

[PDF][PDF] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen… - 2018 - researchgate.net
Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

[PDF][PDF] Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and …

S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen… - Lancet, 2018 - core.ac.uk
Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …